The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

CHICAGO, NY, UNITED STATES, January 17, 2025 /EINPresswire / -- The global insulin pump <a target=_blank href= ...

Closed loop insulin pump therapy lowers the risk for hypoglycemic coma but increases diabetic ketoacidosis risk among patients with T1D.

One of the significant advancements in diabetes management is the use of insulin pump therapy, which provides a continuous supply of insulin to help maintain stable blood glucose levels.

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits, but is officially ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen research firms that are currently covering the company ...

Corporation's stock has reached a new 52-week high, with shares climbing to $282.87. This milestone reflects a significant uptrend for the medical device company, known for its innovative insulin pump ...